Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The Phase 1b clinical study consists of two parts. In Part 1, eight healthy volunteers received a single 300 mg subcutaneous dose of HER-096 to assess its safety and pharmacokinetic properties.